HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
38 hedge funds and large institutions have $14.6M invested in Hepion Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 15 increasing their positions, 2 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3% less call options, than puts
Call options by funds: $1.51M | Put options by funds: $1.56M
Holders
38
Holding in Top 10
–
Calls
$1.51M
Puts
$1.56M
Top Buyers
| 1 | +$2.95M | |
| 2 | +$961K | |
| 3 | +$710K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$577K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
+$564K |
Top Sellers
| 1 | -$2.02M | |
| 2 | -$512K | |
| 3 | -$329K | |
| 4 |
Renaissance Technologies
New York
|
-$314K |
| 5 |
Squarepoint
New York
|
-$245K |